Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6063938 | 0.93 | TSHR (0.44) | TSHRALDH1A1LMNAL3MBTL1LPAR3 | |
| SCHEMBL15302046 | 0.91 | TSHR (0.48) | TSHRALDH1A1LMNALPAR3LPAR2 | |
| SCHEMBL339029 | 0.86 | TSHR (0.39) | TSHRALDH1A1 | |
| SCHEMBL6063876 | 0.83 | TSHR (0.46) | TSHRALDH1A1LMNAL3MBTL1 | |
| SCHEMBL6063325 | 0.81 | TSHR (0.50) | TSHRALDH1A1LMNAL3MBTL1 | |
| SCHEMBL1229121 | 0.77 | TSHR (0.44) | TSHRALDH1A1LMNAL3MBTL1LPAR3 | |
| SCHEMBL6063900 | 0.77 | TSHR (0.46) | TSHRALDH1A1LMNALPAR3LPAR2 | |
| SCHEMBL3331451 | 0.76 | — | — | |
| SCHEMBL15302505 | 0.75 | TSHR (0.50) | TSHRALDH1A1LMNALPAR3LPAR2 | |
| SCHEMBL15302102 | 0.75 | TSHR (0.50) | TSHRALDH1A1LMNALPAR3LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994681-B2 | Organopolysiloxane prepolymer and a curable organopolysiloxane composition comprising the same | HENKEL AG & CO. KGAA (DE) | 2018-06-12 | — | — | US | disclosed |
| EP-3245256-A1 | ORGANOPOLYSILOXANE PREPOLYMER AND CURABLE ORGANOPOLYSILOXANE COMPOSITION COMPRISING SAME | Henkel AG & Co. KGaA (DE) | 2017-11-22 | — | — | EP | disclosed |
| US-20170306100-A1 | Organopolysiloxane Prepolymer and a Curable Organopolysiloxane Composition Comprising the Same | HENKEL CORPORATION | 2017-10-26 | — | — | US | disclosed |
| WO-2016112487-A1 | ORGANOPOLYSILOXANE PREPOLYMER AND CURABLE ORGANOPOLYSILOXANE COMPOSITION COMPRISING SAME | HENKEL (CHINA) COMPANY LIMITED (CN) | 2016-07-21 | — | — | WO | disclosed |
| WO-2016054781-A1 | AN ORGANOPOLYSILOXANE PREPOLYMER AND A CURABLE ORGANOPOLYSILOXANE COMPOSITION COMPRISING THE SAME | HENKEL (CHINA) COMPANY LIMITED (CN) | 2016-04-14 | — | — | WO | disclosed |
| US-8871890-B2 | Curable resin composition and cured article | DAICEL CORPORATION (JP) | 2014-10-28 | — | — | US | disclosed |
| US-8791221-B2 | Addition-curable metallosiloxane compound | DAICEL CORPORATION (JP) | 2014-07-29 | — | — | US | disclosed |
| EP-2650319-A1 | ADDITION-CURABLE METALLOSILOXANE COMPOUND | Daicel Corporation (JP) | 2013-10-16 | — | — | EP | disclosed |
| US-20130267653-A1 | ADDITION-CURABLE METALLOSILOXANE COMPOUND | DAICEL CORPORATION (JP) | 2013-10-10 | — | — | US | disclosed |
| EP-2636706-A1 | CURABLE RESIN COMPOSITION AND CURED ARTICLE | Daicel Corporation (JP) | 2013-09-11 | — | — | EP | disclosed |
| US-20130131265-A1 | CURABLE RESIN COMPOSITION AND CURED ARTICLE | DAICEL CORPORATION (JP) | 2013-05-23 | — | — | US | disclosed |
| US-7015292-B2 | Silicon-containing olefin copolymer, crosslinkable rubber composition thereof, and use thereof | MITSUI CHEMICALS, INC. (JP) | 2006-03-21 | — | — | US | disclosed |
| US-20050038214-A1 | Silicon-containing olefin copolymer, crosslinkable rubber composition thereof, and use thereof | MITSUI CHEMICALS, INC. (JP) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130267653-A1 | ADDITION-CURABLE METALLOSILOXANE COMPOUND | B2M, MSI2, MNS1 | TSHR 4702/4885ALDH1A1 2073/4885LMNA 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.